China SXT Pharmaceuticals (SXTC) Short Interest Ratio & Short Volume $1.66 +0.10 (+6.41%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.62 -0.04 (-2.71%) As of 09:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock China SXT Pharmaceuticals Short Interest DataChina SXT Pharmaceuticals (SXTC) has a short interest of 209,000 shares, representing 1.52% of the float (the number of shares available for trading by the public). This marks a 307.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.13 million shares to cover all short positions.Current Short Interest209,000 sharesPrevious Short Interest51,300 sharesChange Vs. Previous Month+307.41%Dollar Volume Sold Short$489,060.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares723,000 sharesFloat Size13,730,000 sharesShort Percent of Float1.52%Today's Trading Volume785,439 sharesAverage Trading Volume1,133,650 sharesToday's Volume Vs. Average69% Short Selling China SXT Pharmaceuticals? Sign up to receive the latest short interest report for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSXTC Short Interest Over TimeSXTC Days to Cover Over TimeSXTC Percentage of Float Shorted Over Time China SXT Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025209,000 shares $489,060.00 +307.4%1.5%0.1 $2.34 4/15/202551,300 shares $87,210.00 -2.7%0.4%0 $1.70 3/31/202552,700 shares $133,067.50 +60.2%0.4%0.6 $2.53 3/15/202532,900 shares $92,778.00 -54.8%0.2%0.3 $2.82 2/28/202572,800 shares $328,328.00 +1,448.9%3.2%0.4 $4.51 2/15/20254,700 shares $14,363.20 -95.0%0.1%0 $3.06 1/31/202594,100 shares $38,581.00 +129.0%2.7%0.1 $0.41 1/15/202541,100 shares $16,135.86 -89.1%1.2%0 $0.39 12/31/2024377,600 shares $191,858.56 +44.1%11.0%0.4 $0.51 12/15/2024262,000 shares $100,870.00 +263.4%7.6%0.3 $0.39 Get the Latest News and Ratings for SXTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/202472,100 shares $28,840.00 +7.6%2.1%0.1 $0.40 11/15/202467,000 shares $25,935.03 -36.4%2.0%0.1 $0.39 10/31/2024105,300 shares $58,862.70 -46.3%3.1%0.2 $0.56 10/15/2024196,000 shares $123,970.00 -22.1%5.7%0.3 $0.63 9/30/2024251,600 shares $183,617.68 -44.7%7.3%0.3 $0.73 9/15/2024455,300 shares $303,229.80 +744.7%13.1%0.7 $0.67 8/31/202453,900 shares $33,886.93 +32.8%1.6%0.1 $0.63 8/15/202440,600 shares $41,818.00 -23.3%1.2%0.1 $1.03 7/31/202452,900 shares $58,719.00 -68.2%7.6%0.1 $1.11 7/15/2024166,100 shares $195,998.00 +347.7%24.0%0.3 $1.18 6/30/202437,100 shares $40,439.00 -25.1%5.4%0 $1.09 6/15/202449,500 shares $54,450.00 +43.1%9.3%0 $1.10 5/31/202434,600 shares $36,343.84 +76.5%6.5%0 $1.05 5/15/202419,600 shares $21,364.00 +36.1%3.6%0 $1.09 4/30/202414,400 shares $15,264.00 -77.4%2.6%0 $1.06 4/15/202463,600 shares $74,412.00 +142.8%11.6%0.1 $1.17 3/31/202426,200 shares $44,016.00 +376.4%4.8%0 $1.68 3/15/20245,500 shares $9,570.00 -93.4%1.0%0 $1.74 2/29/202482,800 shares $163,116.00 +145.0%15.1%0.1 $1.97 2/15/202433,800 shares $73,684.00 -59.3%6.2%0 $2.18 1/31/202483,000 shares $161,020.00 +538.5%14.8%0.1 $1.94 1/15/202413,000 shares $24,440.00 +100.0%2.3%0 $1.88 12/31/20236,500 shares $25,805.00 -67.3%1.2%0 $3.97 12/15/202319,900 shares $38,805.00 -33.7%3.6%0.1 $1.95 11/30/202330,000 shares $63,600.00 +67.6%5.3%0.2 $2.12 11/15/202317,900 shares $42,602.00 -70.2%3.2%0.1 $2.38 10/31/202360,100 shares $129,221.01 -21.4%10.7%0.3 $2.15 10/15/202376,500 shares $225,675.00 +948.0%13.6%0.3 $2.95 9/30/20237,300 shares $22,447.50 -98.7%0.1%0 $3.08 9/15/2023575,400 shares $75,780.18 +99.7%4.6%0.1 $0.13Here’s your answer (Ad)Porter Stansberry is stepping into the spotlight — and putting real skin in the game. For the first time ever, he’s opening the doors to a live, real-money trading account, managed transparently with the same strategies he’s used to build long-term wealth. Every 90 days, he and his lead analyst release a new tranche of trades designed for serious investors who don’t want to babysit the market. The goal: income, downside protection, and asymmetric upside. Lance James breaks down the full FAQ on what this is (and isn’t) — including why they believe now i 8/31/2023288,100 shares $32,555.30 +553.3%2.4%0.1 $0.11 8/15/202344,100 shares $6,513.57 -61.1%0.4%0 $0.15 7/31/2023113,300 shares $23,113.20 +18.1%1.0%0.2 $0.20 7/15/202395,900 shares $18,796.40 -8.2%1.1%0.1 $0.20 6/30/2023104,500 shares $24,557.50 +5.9%1.2%0.1 $0.24 6/15/202398,700 shares $23,737.35 +4.0%1.2%0.1 $0.24 5/31/202394,900 shares $19,255.21 -69.1%1.1%0.2 $0.20 5/15/2023307,300 shares $69,019.27 +1,034.0%3.6%0.5 $0.22 4/30/202327,100 shares $6,720.80 +942.3%0.3%0 $0.25 4/15/20232,600 shares $621.14 -83.5%0.1%0 $0.24 3/31/202315,800 shares $4,480.88 +13.7%0.5%0 $0.28 3/15/202313,900 shares $4,075.48 -68.3%0.5%0 $0.29 2/28/202343,800 shares $17,182.74 -25.5%1.4%0.1 $0.39 2/15/202358,800 shares $28,812.00 -18.0%1.8%0.1 $0.49 1/31/202371,700 shares $40,144.83 -10.7%2.3%0.1 $0.56 1/15/202380,300 shares $47,377.00 -22.8%1.7%0.1 $0.59 12/30/2022104,000 shares $56,368.00 -68.0%2.2%0.2 $0.54 12/15/2022324,500 shares $195,803.30 +587.5%7.6%0.6 $0.60 11/30/202247,200 shares $33,035.28 +193.2%2.2%0.1 $0.70 11/15/202216,100 shares $10,787.00 -17.0%0.7%0 $0.67 10/31/202219,400 shares $11,640.00 -62.4%0.9%0 $0.60 10/15/202251,600 shares $35,088.00 -16.9%2.4%0.1 $0.68 9/30/202262,100 shares $47,817.00 -50.2%2.8%0.1 $0.77 9/15/2022124,600 shares $139,552.00 -11.3%5.7%0.3 $1.12 8/31/2022140,400 shares $197,262.00 +345.7%6.4%0.3 $1.41 8/15/202231,500 shares $51,345.00 +34.6%1.3%0.2 $1.63 7/31/202223,400 shares $34,164.00 -67.1%1.0%0.2 $1.46 7/15/202271,100 shares $129,402.00 +17.5%4.1%0.7 $1.82 6/30/202260,500 shares $105,875.00 -38.3%3.5%0.6 $1.75 6/15/202298,100 shares $162,846.00 +42.4%5.6%0.3 $1.66 5/31/202268,900 shares $144,690.00 +98.0%4.0%0.2 $2.10 5/15/202234,800 shares $115,118.40 -95.9%2.0%0.1 $3.31 4/30/2022856,400 shares $183,440.88 +7.5%N/A0.1 $0.21 4/15/2022796,400 shares $175,208.00 -84.4%N/A0.1 $0.22 3/31/20225,100,000 shares $1.43 million +1,933.5%38.7%0.5 $0.28 3/15/2022250,800 shares $42,134.40 +19.0%1.9%0 $0.17 2/28/2022210,800 shares $45,954.40 -56.7%1.6%0 $0.22 2/15/2022487,200 shares $89,157.60 -34.7%3.7%0.2 $0.18 1/31/2022746,200 shares $160,656.86 +294.6%5.7%0.3 $0.22 1/15/2022189,100 shares $101,735.80 -32.3%1.4%0.1 $0.54 12/31/2021279,200 shares $181,563.76 +50.6%2.3%0.5 $0.65 12/15/2021185,400 shares $119,564.46 -47.3%1.5%0.4 $0.64 11/30/2021351,800 shares $248,529.46 -31.1%2.9%0.7 $0.71 11/15/2021510,500 shares $433,925.00 -16.6%4.1%1.1 $0.85 10/29/2021612,000 shares $581,767.20 +107.0%5.0%1.3 $0.95 10/15/2021295,600 shares $275,114.92 -18.4%2.4%0.6 $0.93 9/30/2021362,300 shares $373,169.00 -24.4%2.9%0.2 $1.03 9/15/2021479,400 shares $498,576.00 -10.0%3.9%0.2 $1.04 8/31/2021532,900 shares $623,493.00 -3.0%4.3%0.2 $1.17 8/13/2021549,200 shares $648,056.00 -18.8%4.4%0.2 $1.18Elon’s 2025 Silver Crisis (What It Means for You) (Ad)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.I'm offering a new 2025 Silver Wealth Guide and it is now available. 7/30/2021675,900 shares $844,875.00 +38.9%5.1%0.3 $1.25 7/15/2021486,600 shares $729,900.00 -19.5%3.6%0.2 $1.50 6/30/2021604,700 shares $876,815.00 +19.2%4.5%2.5 $1.45 6/15/2021507,300 shares $715,293.00 -5.0%3.8%1.4 $1.41 5/28/2021533,900 shares $688,731.00 -3.2%4.0%0.9 $1.29 5/14/2021551,400 shares $634,110.00 +2.9%4.1%0.8 $1.15 4/30/2021536,100 shares $771,984.00 -19.7%4.0%0.5 $1.44 4/15/2021667,500 shares $987,900.00 +25.5%5.0%0.4 $1.48 3/31/2021531,700 shares $988,962.00 +21.1%4.0%0.2 $1.86 3/15/2021438,900 shares $877,800.00 +34.1%3.3%0.2 $2.00 2/26/2021327,300 shares $680,784.00 -77.3%2.4%0.1 $2.08 2/12/20211,440,000 shares $1.48 million +15.2%N/A0.6 $1.03 1/29/20211,250,000 shares $841,750.00 +15.7%N/A0.2 $0.67 1/15/20211,080,000 shares $683,532.00 +38.2%N/A0.2 $0.63 12/31/2020781,700 shares $269,686.50 +334.5%N/A0.2 $0.35 12/15/2020179,900 shares $55,265.28 +32.4%N/A0.1 $0.31 11/30/2020135,900 shares $40,076.91 +27.5%N/A0 $0.29 11/15/2020106,600 shares $27,982.50 -78.7%N/A0.1 $0.26 10/30/2020500,400 shares $146,367.00 +220.8%N/A0.2 $0.29 10/15/2020156,000 shares $42,057.60 +24.2%N/A0.1 $0.27 9/30/2020125,600 shares $30,746.88 -81.3%N/A0 $0.24 9/15/2020671,200 shares $171,558.72 +377.7%N/A0.2 $0.26 8/31/2020140,500 shares $42,178.10 -60.4%N/A0 $0.30 8/14/2020354,600 shares $131,131.08 +158.8%N/A0.1 $0.37 7/31/2020137,000 shares $54,334.20 +2.2%N/A0 $0.40 7/15/2020134,000 shares $58,263.20 -84.3%1.0%0 $0.43 6/30/2020853,600 shares $469,053.20 +723.9%6.3%0.1 $0.55 6/15/2020103,600 shares $46,640.72 -53.8%0.8%0 $0.45 5/29/2020224,200 shares $88,693.52 -73.5%1.7%0.1 $0.40 SXTC Short Interest - Frequently Asked Questions What is China SXT Pharmaceuticals' current short interest? Short interest is the volume of China SXT Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 209,000 shares of SXTC short. 1.52% of China SXT Pharmaceuticals' shares are currently sold short. Learn More on China SXT Pharmaceuticals' current short interest. What is a good short interest percentage for China SXT Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.52% of China SXT Pharmaceuticals' floating shares are currently sold short. Is China SXT Pharmaceuticals' short interest increasing or decreasing? China SXT Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 209,000 shares, an increase of 307.4% from the previous total of 51,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is China SXT Pharmaceuticals' float size? China SXT Pharmaceuticals currently has issued a total of 723,000 shares. Some of China SXT Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China SXT Pharmaceuticals currently has a public float of 13,730,000 shares. How does China SXT Pharmaceuticals' short interest compare to its competitors? 1.52% of China SXT Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to China SXT Pharmaceuticals: NLS Pharmaceutics Ltd. (5.82%), Mainz Biomed (5.38%), GT Biopharma, Inc. (1.74%), HCW Biologics Inc. (1.03%), Jaguar Health, Inc. (20.36%), 180 Life Sciences Corp. (21.45%), Apollomics, Inc. (1.17%), Ensysce Biosciences, Inc. (6.09%), Sonoma Pharmaceuticals, Inc. (5.09%), Aptorum Group Limited (2.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short China SXT Pharmaceuticals stock? Short selling SXTC is an investing strategy that aims to generate trading profit from China SXT Pharmaceuticals as its price is falling. SXTC shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against China SXT Pharmaceuticals? A short squeeze for China SXT Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SXTC, which in turn drives the price of the stock up even further. How often is China SXT Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SXTC, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies NLS Pharmaceutics Short Interest Mainz Biomed Short Interest GT Biopharma Short Interest HCW Biologics Short Interest Jaguar Health Short Interest 180 Life Sciences Short Interest Apollomics Short Interest Ensysce Biosciences Short Interest Sonoma Pharmaceuticals Short Interest Aptorum Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SXTC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
